(Q40453406)

20 September 2017

title

Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation. (English)

1 reference

20 September 2017

1 reference

4

George Q Daley

0 references

Anthony D Whetton

object named as

Anthony D Whetton

3

0 references

Stephen A. Baldwin

6

object named as

Stephen A Baldwin

1 reference

20 September 2017

Kay Barnes

1

1 reference

20 September 2017

Elizabeth McIntosh

2

1 reference

20 September 2017

Johanne Bentley

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

24

1 reference

20 September 2017

issue

20

1 reference

20 September 2017

page(s)

3257-3267

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208461

20 September 2017

exact match

0 references

cites work

Interleukin-3-mediated cell survival signals include phosphatidylinositol 3-kinase-dependent translocation of the glucose transporter GLUT1 to the cell surface

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

Glucose transport regulation by p210 Bcr-Abl in a chronic myeloid leukaemia model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

Evidence that cell survival is controlled by interleukin-3 independently of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

Apoptosis is regulated by the rate of glucose transport in an interleukin 3 dependent cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

Hemopoietic cell transformation is associated with failure to downregulate glucose uptake during the G2/M phase of the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

Phosphatidylinositol-3 kinase inhibitors reproduce the selective antiproliferative effects of imatinib on chronic myeloid leukaemia progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

The hemopoietic growth factor, interleukin-3, promotes glucose transport by increasing the specific activity and maintaining the affinity for glucose of plasma membrane glucose transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

Role of phosphatidylinositol 3-kinase and specific protein kinase B isoforms in the suppression of apoptosis mediated by the Abelson protein-tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

7 January 2021

BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

7 January 2021

Interleukin-3 protects Bcr-Abl-transformed hematopoietic progenitor cells from apoptosis induced by Bcr-Abl tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

7 January 2021

Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

7 January 2021

Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

7 January 2021

Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

7 January 2021

Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

7 January 2021

Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

7 January 2021

p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

7 January 2021

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

7 January 2021

Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208461

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208461

1 reference

Dimensions Publication ID

20 September 2017

1009227848

0 references

1 reference